Delivery Order SPE2DB22D2214-SPE2DB25FS5FT

Award Date 6/3/25
Potential Completion Date 6/4/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,527.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of December 5, 2024. The award supports the procurement of Pyridostigmine BR 30 MG Tablet medical supplies, which are likely intended for military healthcare programs. Amerisourcebergen holds a...
This federal contract award is for the delivery of pyridostigmine bromide 30 mg tablets to support the Defense Logistics Agency (DLA). The $8,863.10 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The federal contract award is for the delivery of PYRIDOSTIGMINE BR 60 MG TABLET 30S to the Defense Logistics Agency (DLA), a defense agency. The $1,576.82 firm-fixed-price contract has a completion date of February 7, 2025 and was awarded to the prime contractor Amerisourcebergen Drug Corp on February 6, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant...
This federal contract award is for the delivery of 4,565,440 units of pyridostigmine bromide 30 mg tablets to the Defense Logistics Agency (DLA). The $7,824.48 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 13, 2024 with an ultimate completion date of August 14, 2024. The contract does not have a set-aside designation. As a large Indefinite Delivery Contract (IDC) holder with the DLA Troop Support Medical valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,734.33 firm fixed-price delivery order is for the supply of Pyrazinamide tablets, with a period of performance through May 2025. The award is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical. This IDC provides a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,568,267,250 tablets of Pyrazinamide 500 mg, a pharmaceutical product, with a ceiling value of $1,928.93. The contract is a firm fixed-price delivery order with a period of performance ending on May 19, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $807,318.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order contract is for a firm fixed price with an ultimate completion date of January 16, 2025. The contract is not set aside and allows for the provision of a wide range of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain...
This federal contract award, valued at $16,554.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of April 29, 2025. The contract provides for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic categories such as...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $5,475.69 with a completion date of January 9, 2025. The contract was awarded by the Defense Logistics Agency (DLA) and is for the supply of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor and has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $1,856.16 and a period of performance through May 12, 2025. It is not designated as a set-aside contract, indicating open competition. The contract provides for the delivery of a range of pharmaceutical products and medical supplies to support military healthcare...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB25FS5FT
    Delivery Order

This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Pyridostigmine BR 60 MG Tablet 30S, a medical product, with a ceiling value of $1,415.66 and a completion date of June 4, 2025. The contract is designated as a Firm Fixed Price, non-set-aside award, indicating open competition.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs through December 2026. This Delivery Order is likely part of the broader DLA IDC contract, allowing Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 9/2/25, 9:52 AM